Testing JADE201 drug in rheumatoid arthritis patients
Part of Bones, joints & muscles, Immune system & allergy clinical trials.
This early-stage study tests a new drug called JADE201 in people with rheumatoid arthritis (RA). Researchers want to see if it is safe and how the body handles it, which could lead to better RA treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- You weigh between 50–100 kg (110–220 lbs) and have a healthy BMI
- You have been diagnosed with rheumatoid arthritis using standard medical criteria
- You can stay at the research site for the study and attend all visits and tests
- You do not have other serious diseases or autoimmune conditions besides RA
- You are not pregnant, nursing, or planning to become pregnant during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called JAB-8263 for people with active rheumatoid arthritis. It aims to see if the drug can help reduce inflammation and improve symptoms.
This trial tests a new medication (BMS-986454) for people with rheumatoid arthritis who haven't responded well enough to methotrexate. It aims to see if the drug is safe and how it works in the body.
This trial tests taking a JAK inhibitor (a type of pill that helps calm inflammation in rheumatoid arthritis) by mouth. It aims to see how well it works and if it's safe for people with RA who need this kind of medicine.
This trial tests an experimental drug for people with rheumatoid arthritis who have not had success with other treatments. It aims to see if the drug can help reduce joint pain and swelling.
This trial tests a new medication called ADI-001 to see if it can help people with rheumatoid arthritis. It is for adults who meet the standard criteria for RA and are in generally good health otherwise.
This study tests a new medication called AZD1163 for people with rheumatoid arthritis (RA) that hasn't responded well enough to standard treatments. It aims to see if the drug can safely reduce joint swelling and pain.
Hear when a new Rhematoid Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.